Asset Details
Do you wish to reserve the book?
The challenge of pharmacogenetics and pharmacogenomics
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The challenge of pharmacogenetics and pharmacogenomics
Do you wish to request the book?
The challenge of pharmacogenetics and pharmacogenomics
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The challenge of pharmacogenetics and pharmacogenomics
2000
Overview
The Human Genome Project along with a number of rival commercial and academic efforts such as that of Celera Genomics looks set to provide a comprehensive map and sequence of the human genome within the next two to three years. The development of techniques in genetic engineering has given us the ability to identify and isolate many genes that are important to the understanding of disease. The pharmaceutical industry is being flooded with information as it enters a period both of prodigious complexity and unprecedented opportunity. The challenge for the industry will be in selecting the best therapeutic targets among the huge number that present themselves. The future of drug development may well lie in the efficient identification of these targets that are most receptive to therapeutic attack.
Publisher
Taylor & Francis,Taylor & Francis Ltd
Subject
